Abstract:BACKGROUND: The incidence of hepatocellular carcinoma (HCC) in China is closely related to the population infected with hepatitis B virus (HBV). HCC cells with HBV secrete soluble HBsAg into blood but do not express it on the cell membrane. This study aimed to construct and investigate a new glycosylphosphatidylinositol (GPI)-anchored protein (GPC3+alpha+EGFP) as a DNA vaccine against HCC associated with HBV.METHODS: A recombinant plasmid (pcDNA3.1(+)/GPC3+alpha+EGFP) was constructed and verified by restriction endonuclease digestion and sequencing. pcDNA3.1(+)/GPC3+alpha+EGFP was transfected into HepG2 cells (experimental group) using lipofectamine 2000. pEGFP-N1-transfected HepG2 cells were used as a negative control, and non-transfected HepG2 cells sreved as a blank control. HepG2 cells that steadily expressed the fusion protein GPC3+alpha+EGFP were screened by G418, propagated, and co-cultured with lymphocytes from healthy donors. Cell proliferation was measured by the classic sulforhodamine B assay. Apoptosis was assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and Fas gene transcription was determined by quantitative fluorescent PCR.RESULTS: The pcDNA3.1(+)/GPC3+alpha+EGFP plasmid was successfully constructed. In the experimental group, green fluorescence was observed at the cell periphery and in the cytoplasm, whereas in the negative control group, fluorescence was evenly distributed throughout the cell. Proliferation of the experimental group significantly decreased after 72 hours compared to the negative and blank control groups. Furthermore, the number of apoptotic cells was statistically different among the three groups as determined by a contingency table Chi-square test; the experimental group had the highest incidence of apoptosis. Fas gene transcription in the experimental group was higher than in the two control groups, and an increasing trend with time in the experimental group was observed.CONCLUSION: A chimeric, membrane-anchored protein, GPC3+alpha+EGFP, localized to the membrane of HepG2 cells and inhibited proliferation and accelerated apoptosis through a Fas-FasL pathway after co-cultivation with lymphocytes.

A possible receptor for β2 glycoprotein I on the membrane of hepatoma cell line smmc7721

Asialoglycoprotein Receptor Interacts with the Pres1 Domain of Hepatitis B Virus in Vivo and in Vitro

Protein Expression and Fucosylated Glycans of the Serum Haptoglobin-Beta Subunit in Hepatitis B Virus-Based Liver Diseases

Screening, Expression and Characterization of a Novel Protein Binding to Hepatitis B Surface Antigen

Gpc3 Fused to an Alpha Epitope of Hbsag Acts As an Immune Target Against Hepatocellular Carcinoma Associated with Hepatitis B Virus

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry.

Interaction of S17 Antibody with the Functional Binding Region of the Hepatitis B Virus Pre-S2 Epitope

Identification and Characterization of Peptides That Interact with Hepatitis B Virus Via the Putative Receptor Binding Site.

Identification of Differential HLA-binding Peptide Between Two Hepatoma Cell Lines HepG2 and HepG2.2.15

Cellular Localization of HCBP1 and Its Interaction with HCV Core Protein in Vivo

Screening and Identification of Interacting Proteins with Hepatitis B Virus Core Protein in Leukocytes and Cloning of New Gene C1

Ferritin Light Chain and Squamous Cell Carcinoma Antigen 1 Are Coreceptors for Cellular Attachment and Entry of Hepatitis B Virus

Screening and characterization of hepatic B virus Pre-S2 binding proteins by phage display system

Glt25D2, an O-glycosyltransferase is related with the secretion of hepatitis B virus surface large protein

Identification of Beta-1,4-Galactosyltransferase I As A Target Gene of Hbx-Induced Cell Cycle Progression of Hepatoma Cell

N-glycopeptide Signatures of IgA2 in Serum from Patients with Hepatitis B Virus-related Liver Diseases.

Proteome Responses to Stable Hepatitis B Virus Transfection and Following Interferon Alpha Treatment in Human Liver Cell Line HepG2.

Α-2-hs-glycoprotein is a Potential Marker Predicting Hepatitis B E Antigen Seroconversion in Patients with Chronic Hepatitis B During Treatment with Pegylated Interferon Alfa-2B

Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein

Hepatitis B Virus (HBV) Receptors: Deficiency in Tumor Results in Scant HBV Infection and Overexpression in Peritumor Leads to Higher Recurrence Risk.

Gene-expression Profiles of a Hepatitis B Small Surface Antigen-Secreting Cell Line Reveal Upregulation of Lymphoid Enhancer-Binding Factor 1